enVVeno Medical Corporation NVNO
8.67
(0.42)
(4.62%)
as of 25 Sep
- Market cap
- $6.3M
- P/E
- 0.0×
Follow NVNO
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
12.90 | 13.30 | 11.63 | 11.39 | |
Current Ratio |
13.12 | 13.58 | 11.89 | 11.70 | |
Net Debt/EBITDA |
6.50 | 7.24 | 6.33 | 5.70 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.97 | 0.92 | 0.84 | 0.99 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(7.65) | (5.85) | (4.95) | (5.29) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(7.65) | (5.85) | (4.95) | (5.29) | |
Cash per Share |
53.89 | 47.90 | 38.12 | 32.02 | |
Shareholders Equity per Share |
51.27 | 46.06 | 36.31 | 30.80 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
51.27 | 46.06 | 36.31 | 30.80 | |
Free Cash Flow |
(4.39) | (3.44) | (3.24) | (3.55) | |
Working Capital |
29.10 | 26.70 | 23.35 | 20.20 | |
Capital Expenditures |
0.00 | 0.00 | — | — | |
Net Current Asset Value |
28.59 | 26.39 | 23.14 | 20.09 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | — | — | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Payables |
1.99 | 1.73 | 1.52 | 2.06 | |
Average Assets |
41.37 | 37.26 | 33.34 | 29.62 | |
Average Common Equity |
38.41 | 34.64 | 31.03 | 26.86 |
Columns are period end dates